Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ARI Launches New Assay Prep System for Drug Discovery

Published: Tuesday, November 06, 2012
Last Updated: Tuesday, November 06, 2012
Bookmark and Share
Non-contact dispenser sets a new benchmark for flexible, low-volume assay assembly.

Art Robbins Instruments (ARI) has announced the launch of their Cobra 148 non-contact dispensers. These affordably-priced liquid handling systems were designed for use in a wide range of drug discovery applications and enable low-volume, non-contact reagent dispensing for assay assembly and plate preparation.

Rapid, reliable assembly of assay reagents is critical for biochemical and cell-based assay development, especially when low-volume assays are required.

The Cobra 148 systems finally provide assay developers with the freedom and flexibility to design assays using precious or costly reagents and cells without constraint, dispensing them at low volumes in a microplate format.

Scientists have complete control over the volume dispensed, and can set individual well dispense volumes to as low as 300 nanoliters, enabling complex concentration gradients and even sparse-matrix assay development strategies.

Researchers in drug discovery and other areas that require a large number of data points per assay are now also able to dispense a broad range of volumes of up to four reagents into 96-, 384- and 1536-well microplates.

With an option for on-the-fly dispensing, 300 nanoliters can be dispensed into an entire 384 well microplate in 14 seconds. Twenty-five microliters require only 39 seconds.

Aspiration and dispensing from microplates is a standard feature in the 1 and 4 channel models, virtually eliminating dead volumes and preserving precious reagents.

A dedicated 8-channel bulk dispensing system is available for very high throughput applications.

“Assembling microplate-based assays is a fundamental part of drug discovery and life science research, the instrumentation has to be fast, robust and fit seamlessly into user’s workflows” commented Art Robbins, founder of ARI.

Robbins continued, “We’ve applied our years of experience in developing non-contact dispensers for protein crystallography applications to the Cobra 148 systems so that researchers can take advantage of the same speed and reliability for their assay development and screening applications.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Honey’s Potential to Save Lives
The healing powers of honey have been known for thousands of years.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!